References

1. 1.
   JOHNSTON S，FRASER A，BIDDLE C，et al.Like a punch in the gut：A novel perspective on annual recurrences of ulcerative colitis［J］.Crohns Colitis 360，2024，6（4）：otae050.
2. 2.
   TAN W W，LIU Z X，LIU X Y，et al.Abdominal pain in inflammatory bowel disease-epidemiology，pathophysiology，and management：A narrative review［J］.Pain Ther，2024，13（6）：1447-1469.
3. 3.
   RIVERA A P，FLORES MONAR G V，ISLAM H，et al.Ulcerative colitis-induced colorectal carcinoma：A deleterious concatenation［J］.Cureus，2022，14（2）：e22636.
4. 4.
   BOARU D L，FRAILE-MARTINEZ O，DE LEON-OLIVA D，et al.Harnessing the anti-inflammatory properties of polyphenols in the treatment of inflammatory bowel disease［J］.Int J Biol Sci，2024，20（14）：5608-5672.
5. 5.
   GUAZELLI C F S，FATTORI V，COLOMBO B B，et al.Development of trans-chalcone loaded pectin/casein biodegradable microcapsules：Efficacy improvement in the management of experimental colitis［J］.Int J Pharm，2023，642：123206.
6. 6.
   WANG Z，LI L S.Exploring the differentiation and treatment of depression based on the metaholistic view of "turbidity harms cleanliness"［J］.J Sichuan Tradit Chin Med，2024，42（1）：57-61.
7. 7.
   WEN Y，XU Y K，SUN M L，et al.Analysis of stroke with damp-heat pattern on basis of the theory "turbid evil invading the clear orifice"［J］.J Beijing Univ Tradit Chin Med，2021，44（11）：987-991.
8. 8.
   COSTELLO S P，HUGHES P A，WATERS O，et al.Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis：A randomized clinical trial［J］.JAMA，2019，321（2）：156-164.
9. 9.
   UNGARO R，MEHANDRU S，ALLEN P B，et al.Ulcerative colitis［J］.Lancet，2017，389（10080）：1756-1770.
10. 10.
    WU Y Q，JHA R，LI A，et al.Probiotics （lactobacillus plantarum hnu082） supplementation relieves ulcerative colitis by affecting intestinal barrier functions，immunity-related gene expression，gut microbiota，and metabolic pathways in mice［J］.Microbiol Spectr，2022，10（6）：e0165122.
11. 11.
    SUN M Y，QIN H W，LI Y J，et al.To explore the influence of intestinal flora on arteriosclerosis and the progress of Chinese medicine intervention based on Yingwei theory［J］.J Liaoning Univ Tradit Chin Med，2023，25（7）：64-69.
12. 12.
    TAN Y，GUAN Y D，SUN Y，et al.Correlation of intestinal mucosal healing and tight junction protein expression in ulcerative colitis patients［J］.Am J Med Sci，2019，357（3）：195-204.
13. 13.
    WU Y， JIA L Q，SONG N，et al.Based on Yingwei theory to explore the effect of "Sunluo-microvessel" proliferation on atherosclerosis［J］.Lishizhen Med Mater Med Res，2019，30（2）：415-417.
14. 14.
    KOBAYASHI T，SIEGMUND B，LE BERRE C，et al.Ulcerative colitis［J］.Nat Rev Dis Primers，2020，6（1）：74.
15. 15.
    SHEN Z H，ZHU C X，QUAN Y S，et al.Relationship between intestinal microbiota and ulcerative colitis：Mechanisms and clinical application of probiotics and fecal microbiota transplantation［J］.World J Gastroenterol，2018，24（1）：5-14.
16. 16.
    GUO W Q，WANG Q，GUO G，et al.Discussion on the connotation of "spleen being the origin of acquired constitution" based on intestinal microbiota［J］.China J Tradit Chin Med Pharm，2021，36（9）：5165-5168.
17. 17.
    FUKUDA S，TOH H，HASE K，et al.Bifidobacteria can protect from enteropathogenic infection through production of acetate［J］.Nature，2011，469（7331）：543-547.
18. 18.
    ZHANG X S，YANG A Q，SHI L，et al.The Influence of time rhythm and immune system on the pathogenesis of ulcerative colitis based on the theory of Wei Qi［J］.J Tradit Chin Med，2025，66（3）：238-243.
19. 19.
    TONG Y L，YU Y F，CHEN Y，et al.Discussion on the diagnosis and treatment of bipolar disorder by acupuncture and moxibustion based on the theory of "the Qi circles in the body"［J］.J Guangzhou Univ Tradit Chin Med，2023，40（8）：2085-2091.
20. 20.
    ZHENG X B，ZHU Y，YUAN Y，et al.To explore the bidirectional effects of ulcerative colitis and depression and anxiety based on "depression caused by illness and depression caused by depression"［J］.Lishizhen Med Mater Med Res，2022，33（6）：1421-1423.
21. 21.
    YUAN X M，CHEN B Q，DUAN Z L，et al.Depression and anxiety in patients with active ulcerative colitis：Crosstalk of gut microbiota，metabolomics and proteomics［J］.Gut Microbes，2021，13（1）：1987779.
22. 22.
    JIANG Y，YAN Y，WANG Q，et al.A study on the genesis of metaphysical theory［J］.J Tradit Chin Med，2017，58（8）：710-712.
23. 23.
    CHENG Y，Kou F S，Li J X，et al.Treatment of intestinal barrier dysfunction in ulcerative colitis from the perspective of "Xuanfu-crypt"［J］.Chin J Inf Tradit Chin Med，2024，31（6）：167-170.
24. 24.
    HUANG P P，Ma X C.Differentiation and treatment of ischemic heart failure from the theory of "Xuanfu-complex-gas-liquid"［J］.Chin J Integr Med Cardio-Cerebrovasc Dis，2024，22（19）：3633-3634.
25. 25.
    ZHAO Z R，YANG Y X，WANG Y R，et al.Discussion on application of theory of "one Yin as the sole envoy" in treatment of ulcerative colitis［J］.Chin Arch Tradit Chin Med，2024，42（12）：175-179.
26. 26.
    STANGE E F.Mitochondria in ulcerative colitis［J］.Cell Mol Gastroenterol Hepatol，2021，12（1）：352-353.
27. 27.
    ZHANG Z Y，HU R P，ZHU L Y，et al.Discussion on ZHU Danxi's "Yang often Yu" and "Qingyang"［J］.Chin Naturopath，2023，31（20）：10-14.
28. 28.
    HO G T，THEISS A L.Mitochondria and inflammatory bowel diseases：Toward a stratified therapeutic intervention［J］.Annu Rev Physiol，2022，84：435-459.
29. 29.
    HU K W，Wei Y.The relationship between the development of malignant tumor and the spleen and stomach function［J］.China J Tradit Chin Med Pharm，2011，26（11）：2510-2512.
30. 30.
    ZHOU Y T，Wang C.Professor WANG Chen's experience in treating chronic renal failure by using acrid opening and bitter discharge［J］.Liaoning J Tradit Chin Med，2025，52（6）：22-26.
31. 31.
    ZHANG X P，WANG Q Y，ZHONG Z T，et al.Pathogenesis of spleen and stomach diseases and therapeutic effect of Banxia Xiexintang based on theory of "mutual interference of clear and turbid Qi" in Huangdi Neijing［J］.Chin J Exp Tradit Med Form，2024，30（14）：225-231.
32. 32.
    FANG M J，CHEN H R，FU X S，et al.Discussion the treatment of slow-transit constipation with "wind medicine" based on the theory of "rising first for subsequent descending"［J］.Liaoning J Tradit Chin Med，2025，52（7）：9-12.
33. 33.
    HUANG Q，WAN Q，LIU Z Y.Prescription for atherosclerosis based on correlation between spleen-stomach's lifting and lowering theory and intestinal microecology［J］.Lishizhen Med Mater Med Res，2021，32（6）：1421-1424.
34. 34.
    WU J W，WEI Z H，CHENG P，et al.Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis［J］.Theranostics，2020，10（23）：10665-10679.
35. 35.
    HUANG Z，MEN Y N，LEI C F，et al.Discussion on the influence of intestinal microecology on bipolar disorder based on the "relative equilibrium of Yin-Yang" theory［J］.China J Tradit Chin Med Pharm，2023，38（7）：3388-3391.
36. 36.
    YU A I，ZHAO L L，EATON K A，et al.Gut microbiota modulate CD8 T cell responses to influence colitis-associated tumorigenesis［J］.Cell Rep，2020，31（1）：107471.
37. 37.
    XIONG T X，ZHENG X，ZHANG K，et al.Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS/TLR4/NF-κB pathway［J］.J Ethnopharmacol，2022，289：115001.
38. 38.
    TSAI Y C，TAI W C，LIANG C M，et al.Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease［J］.J Microbiol Immunol Infect，2025，58（1）：62-69.
39. 39.
    HAN H F，GAO M，WANG F H，et al.Protective effects of patchouli alcohol against DSS-induced ulcerative colitis［J］.Sci Rep，2024，14（1）：16745.
40. 40.
    LI X H，LIU L，WU W Z.Trans-anethole alleviates DSS-induced ulcerative colitis by remodeling the intestinal flora to regulate immunity and bile acid metabolism［J］.Mediat Inflamm，2023，2023：4188510.
41. 41.
    ZHANG L R，ZHANG W F.Research progress of Wumeiwan in treatment of ulcerative colitis［J］.Chin J Exp Tradit Med Form，2025，31（20）：287-298.
42. 42.
    WU H Q，MU C L，XU L P，et al.Host-microbiota interaction in intestinal stem cell homeostasis［J］.Gut Microbes，2024，16（1）：2353399.
43. 43.
    HUANG H，YAN S，GUO T W，et al.Bile acid metabolism modulates intestinal immunity involved in ulcerative colitis progression［J］.Heliyon，2024，10（14）：e34352.
44. 44.
    LIN S，WANG S T，WANG P，et al.Bile acids and their receptors in regulation of gut health and diseases［J］.Prog Lipid Res，2023，89：101210.
45. 45.
    LIU M，XIE W J，ZHANG X，et al.Sodium butyrate regulates macrophage polarization by TGR5/β-arrestin2 in vitro［J］.Mol Med，2025，31（1）：31.
46. 46.
    MEESSEN E C E，MAJAIT S，AY Ü，et al.Glycodeoxycholic acid inhibits primary bile acid synthesis with minor effects on glucose- and lipid homeostasis in humans［J］.J Clin Endocrinol Metab，2025，110（5）：1468-1477.
47. 47.
    CHEN B T，BAI Y，TONG F L，et al.Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes［J］.Gut Microbes，2023，15（1）：2192155.
48. 48.
    CHEN I，CASSARO S.Physiology，bile acids［M］.Treasure Island （FL）：StatPearls Publishing，2025.
49. 49.
    ZHANG Y，ZHANG X B，SHEN T.Discussion on treatment of glucose and lipid metabolism diseases from the perspective of mutual interference of clear and turbid Qi［J］.J Nanjing Univ Tradit Chin Med，2023，39（8）：707-714.
50. 50.
    HUANG Y，ZHU W Y，SONG W，et al.Differentiation and treatment of lipid turbidity disease based on theory of "spleen ascending and stomach descending"［J］.Chin J Exp Tradit Med Form，2025，31（3）：244-252.
51. 51.
    CHEN J X，PAN M Y，SUN X L，et al.Recent progress in regulatory mechanism and pharmacological intervention of glucose and lipid metabolism on ulcerative colitis［J］.Chin J Bioprocess Eng，2025，23（1）：70-76.
52. 52.
    YUAN J S，ZHOU M Y，LENG Y L，et al.To explore the role of the theory of "ascending lucidity and descending turbidity" in diabetic peripheral neuropathy based on intestinal microbiota imbalance［J］.Mod Tradit Chin Med Mater Med World Sci Technol，2023，25（4）：1494-1501.
53. 53.
    HONG W L，PENG X Y，ZHOU X，et al.FXR/ASS1 axis attenuates the TAA-induced liver injury through arginine metabolism［J］.Biochem Biophys Res Commun，2022，611：31-37.
54. 54.
    HAN J，WEN Y Q，XU Z Y，et al.Mechanisms of "homotherapy for heteropathy" of intrahepatic cholestasis and ulcerative colitis by Zhuyuwan［J］.Chin J Exp Tradit Med Form，2025，31（13）：46-53.
55. 55.
    BAI X，DUAN Z G，DENG J J，et al.Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism［J］.J Adv Res，2025，72：37-52.
56. 56.
    XIAO Y，JIA Y Q，LIU W J，et al.Pulsatilla decoction alleviates DSS-induced UC by activating FXR-ASBT pathways to ameliorate disordered bile acids homeostasis［J］.Front Pharmacol，2024，15：1399829.
57. 57.
    TANG P，ZHA L，YE C，et al.Research progress on the carcinogenesis mechanism of inflammation in ulcerative colitis：A narrative review［J］.Ann Palliat Med，2021，10（11）：11994-12002.
58. 58.
    MA W W，HUANG Z Q，LIU K，et al.The role of intestinal microbiota and metabolites in intestinal inflammation［J］.Microbiol Res，2024，288：127838.
59. 59.
    YUAN Y Y，WANG F，LIU X X，et al.The role of AMPK signaling in ulcerative colitis［J］.Drug Des Dev Ther，2023，17：3855-3875.
60. 60.
    QU F F，WU Y Q，JI J B，et al.The CCL5/CCR5 axis in ulcerative colitis［J］.Cell Immunol，2025，407：104891.
61. 61.
    HE Z Q，XU X，CHEN Y G，et al.Integrated network pharmacology and bioinformatics to identify therapeutic targets and molecular mechanisms of Huangkui Lianchang decoction for ulcerative colitis treatment［J］.BMC Complement Med Ther，2024，24（1）：280.
62. 62.
    VOSHAGH Q，ANOSHIRAVANI A，KARIMPOUR A，et al.Investigating the association between the tissue expression of miRNA-101 ，JAK2/STAT3 with TNF-α，IL-6，IL-1β，and IL-10 cytokines in the ulcerative colitis patients［J］.Immun Inflamm Dis，2024，12（3）：e1224.
63. 63.
    KE J Y，SONG J B，LI L，et al.Advancements of macrophages involvement in pathological progression of colitis-associated colorectal cancer and associated pharmacological interventions［J］.Chin J Integr Med，2024，30（6）：565-576.
64. 64.
    LI M Z，NIU Y Y，ZHANG T C，et al.Wenshen Tongluo Zhitong Prescription regulating the polarization of macrophages through SENP1-SIRT3 pathway to improve the osteogenic differentiation of bone marrow mesenchymal stem cells and bone loss in orchiectomy mice［J］.China J Tradit Chin Med Pharm，2024，39（9）：4619-4626.
65. 65.
    WANG Y F，WANG Y X，CHEN H，et al.Exploration of the mechanism of immune imbalance in ulcerative colitis based on the theory of "harmful hyperactivity and responding inhibition"［J］.J Basic Chin Med，2024，30（12）：2031-2035.
66. 66.
    YANG Z H，LIN S S，FENG W Y，et al.A potential therapeutic target in traditional Chinese medicine for ulcerative colitis：Macrophage polarization［J］.Front Pharmacol，2022，13：999179.
67. 67.
    WANG P T，LI Z X，SONG Y X，et al.Resveratrol-driven macrophage polarization：Unveiling mechanisms and therapeutic potential［J］.Front Pharmacol，2024，15：1516609.
68. 68.
    TAO Q，LIANG Q，FU Y，et al.Puerarin ameliorates colitis by direct suppression of macrophage M1 polarization in DSS mice［J］.Phytomedicine，2024，135：156048.
69. 69.
    YU W，WANG G L，LU C，et al.Pharmacological mechanism of Shenlingbaizhu formula against experimental colitis［J］.Phytomedicine，2022，98：153961.
70. 70.
    PATEL S G，DOMINITZ J A.Screening for colorectal cancer［J］.Ann Intern Med，2024，177（4）：ITC49-ITC64.
71. 71.
    MOHAPATRA B，LAVUDI K，KOKKANTI R R，et al.Regulation of NLRP3/TRIM family signaling in gut inflammation and colorectal cancer［J］.Biochim Biophys Acta Rev Cancer，2025，1880（2）：189271.
72. 72.
    WANG Y N，CHEN Y F，ZHAO M M.N6-methyladenosine modification and post-translational modification of epithelial-mesenchymal transition in colorectal cancer［J］.Discov Oncol，2024，15（1）：209.
73. 73.
    TANG Y，LIU Y，WANG X B，et al.OLFM2 promotes epithelial-mesenchymal transition，migration，and invasion in colorectal cancer through the TGF-β/Smad signaling pathway［J］.BMC Cancer，2024，24（1）：204.
74. 74.
    EMILE M H，EMILE S H，EL-KAREF A A，et al.Association between the expression of epithelial-mesenchymal transition （EMT）-related markers and oncologic outcomes of colorectal cancer［J］.Updat Surg，2024，76（6）：2181-2191.
75. 75.
    NIU W W，LIU Q，HUO X X，et al.TL1A promotes metastasis and EMT process of colorectal cancer［J］.Heliyon，2024，10（2）：e24392.
76. 76.
    SUN L B，XING J P，ZHOU X P，et al.Wnt/β-catenin signalling，epithelial-mesenchymal transition and crosslink signalling in colorectal cancer cells［J］.Biomed Pharmacother，2024，175：116685.
77. 77.
    ZHANG G A，HOU S，LI S Y，et al.Role of STAT3 in cancer cell epithelial‑mesenchymal transition （Review）［J］.Int J Oncol，2024，64（5）：48.
78. 78.
    Xie J K，Xu X N，Ai F T，et al.Pathogenesis and treatment of "inflammation-cancer transformation" of ulcerative colitis based on "Kenang" theory［J］.China J Chin Mater Med，2025 ，50 （8） ：2298-2304.
79. 79.
    CUI H T，JIN Y T，WANG N，et al.Mechanic evaluation of Wu-Mei-pill on colitis-associated colorectal cancer：An integrated transcriptomics，metabolomics，and experimental validation study［J］.Phytomedicine，2024，128：155509.
80. 80.
    OSEI G Y，ADU-AMANKWAAH G，KOOMSON S，et al.MicroRNAs and colorectal cancer：Clinical potential and regulatory networks［J］.Mol Biol Rep，2023，50（11）：9575-9585.
81. 81.
    BROCKMUELLER A，DE PORRAS V R，SHAKIBAEI M.Curcumin and its anti-colorectal cancer potential：From mechanisms of action to autophagy［J］.Phytother Res，2024，38（7）：3525-3551.
82. 82.
    GUO M，YU W Y，ZHU N C，et al.Invasion and metastasis in colorectal cancer mediated by traditional Chinese medicine via cell signaling pathway：A review［J］.Chin J Exp Tradit Med Form，2025，31（4）：323-330.
83. 83.
    GE H Z，XU C，CHEN H T，et al.Traditional Chinese medicines as effective reversals of epithelial-mesenchymal transition induced-metastasis of colorectal cancer：Molecular targets and mechanisms［J］.Front Pharmacol，2022，13：842295.
84. 84.
    LU L，LI J.Mechanism of quercetin on regulating the biological activity of the JAK2/STAT3 signaling pathway on rectal cancer cells［J］.Chin J Curr Adv Gen Surg，2023，26（1）：7-12.
85. 85.
    LIU Y，ZHANG J T，SUN M，et al.Targeting ferroptosis in the treatment of ulcerative colitis by traditional Chinese medicine：A novel therapeutic strategies［J］.Phytomedicine，2025，139：156539.
86. 86.
    QIN C，LI F P ，RUI X，et al.Research progress of ferroptosis in ulcerative colitis［J］.Acta Acad Med Sin，2024，46（4）：619-624.
87. 87.
    BAO H H，WANG Y，XIONG H L，et al.Mechanism of iron ion homeostasis in intestinal immunity and gut microbiota remodeling［J］.Int J Mol Sci，2024，25（2）：727.
88. 88.
    RU Q，LI Y S，CHEN L，et al.Iron homeostasis and ferroptosis in human diseases：Mechanisms and therapeutic prospects［J］.Sig Transduct Target Ther，2024，9（1）：271.
89. 89.
    WANG Y J，FU Q，ZHU X Y，et al.Discussion on the treatment of lung cancer based on iron death from the "Yin Qi and Yang Qi circulating out of order"［J］.China J Tradit Chin Med Pharm，2024，39（7）：3345-3348.
90. 90.
    SHEN X H，AN J R，YANG Y F，et al.Exploring the pathogenesis of T2DM based on the correlation between "Qi-fire imbalance" and ferroptosis［J］.J Tradit Chin Med，2023，64（17）：1759-1762.
91. 91.
    CHEN Y，GUO X Y，ZENG Y C，et al.Oxidative stress induces mitochondrial iron overload and ferroptotic cell death［J］.Sci Rep，2023，13（1）：15515.
92. 92.
    ZHANG X D，LIU Z Y，WANG M S，et al.Mechanisms and regulations of ferroptosis［J］.Front Immunol，2023，14：1269451.
93. 93.
    WANG Y Y，HAO Y W，YUAN L L，et al.Ferroptosis：A new mechanism of traditional Chinese medicine for treating ulcerative colitis［J］.Front Pharmacol，2024，15：1379058.
94. 94.
    LI W W，WANG Y，ZHANG Y，et al.Lizhong decoction ameliorates ulcerative colitis by inhibiting ferroptosis of enterocytes via the Nrf2/SLC7A11/GPX4 pathway［J］.J Ethnopharmacol，2024，326：117966.
95. 95.
    CHEN Y E，ZHU S M，CHEN Z W，et al.Gingerenone a alleviates ferroptosis in secondary liver injury in colitis mice via activating Nrf2-Gpx4 signaling pathway［J］.J Agric Food Chem，2022，70（39）：12525-12534.
96. 96.
    KONG J R，SHI G X，HOU J，et al.Effect of Glycyrrhizae Radix et Rhizoma-containing serum on LPS-induced inflammation in Caco2 cells based on inhibition of ferroptosis by Nrf2/HO-1 pathway［J］.Chin J Exp Tradit Med Form，2023，29（16）：144-153.
97. 97.
    CORRADO A，GUADAGNI I，PICARELLI G，et al.Obesity and chronic inflammation：Implications for rheumatoid arthritis，spondyloarthritis，and ulcerative colitis［J］.Immun Inflamm Dis，2025，13（1）：e70080.
98. 98.
    LV L，CHEN Z Y，BAI W H，et al.Taurohyodeoxycholic acid alleviates trinitrobenzene sulfonic acid induced ulcerative colitis via regulating Th1/Th2 and Th17/Treg cells balance［J］.Life Sci，2023，318：121501.
99. 99.
    SUN X，HUANG Y，ZHANG Y L，et al.Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells［J］.World J Gastroenterol，2020，26（48）：7593-7602.
100. 100.
     WANG S P，HUANG J D，LIU F，et al.Isosteviol sodium exerts anti-colitic effects on BALB/c mice with dextran sodium sulfate-induced colitis through metabolic reprogramming and immune response modulation［J］.J Inflamm Res，2021，14：7107-7130.
101. 101.
     JANTZ-NAEEM N，GUVENCLI N，BÖTTCHER-LOSCHINSKI R，et al.Metabolic T-cell phenotypes：From bioenergetics to function［J］.Am J Physiol Cell Physiol，2025，328（3）：C1062-C1075.
102. 102.
     YIN S J，LI L H，CHEN X L，et al.Artesunate alleviated murine ulcerative colitis by regulating immune response through inhibiting endoplasmic reticulum stress［J］.Front Immunol，2025，16：1545468.
103. 103.
     CHANDWASKAR R，DALAL R，GUPTA S，et al.Dysregulation of T cell response in the pathogenesis of inflammatory bowel disease［J］.Scand J Immunol，2024，100（6）：e13412.
104. 104.
     WANG J，GUO Z Y，SHEN M Y，et al.Potential application mechanism of traditional Chinese medicine in treating immune checkpoint inhibitor-induced colitis［J］.Front Immunol，2024，15：1366489.
105. 105.
     LI J X，MA Y C，LI X F，et al.Fermented Astragalus and its metabolites regulate inflammatory status and gut microbiota to repair intestinal barrier damage in dextran sulfate sodium-induced ulcerative colitis［J］.Front Nutr，2022，9：1035912.
106. 106.
     WANG J L，LI H T.Exploration on the theory of ‘clear-turbid' in Huangdi Neijing［J］.China J Tradit Chin Med Pharm，2024，39（6）：2743-2747.
107. 107.
     SHEN X X.Yin-Yang theory：From ancient philosophy to cutting-edge medical science［J］.Guiding J Tradit Chin Med Pharm，2018，24（4）：1-6.
108. 108.
     GE W，YUAN W Y，AI Z L，et al.Preliminary study on pathogenesis of cold and heat mixed diseases［J］.Chin J Tradit Chin Med，2023，38（4）：1744-1748.
109. 109.
     YIN J Q，LI L Q，XIE S.Research progress on traditional Chinese medicine interventions in Th1/Th2 balance for ulcerative colitis［J］.Chin Tradit Patent Med，2025，47（4）：1228-1234.
110. 110.
     ZHANG L C，MA X F，LIU P，et al.Treatment and mechanism of fecal microbiota transplantation in mice with experimentally induced ulcerative colitis［J］.Exp Biol Med（Maywood），2021，246（13）：1563-1575.
111. 111.
     PAN Q H，LIU Y，WEI S F.Study on the mechanism of Sishen pill in regulating immune balance and secreting inflammatory cytokines through Th17/Treg signaling pathway in the treatment of ulcerative colitis［J］.Chin Arch Tradit Chin Med，2025，43（7）：68-71.
112. 112.
     LIU Y，DONG Y H，SHEN W，et al.Platycodon grandiflorus polysaccharide regulates colonic immunity through mesenteric lymphatic circulation to attenuate ulcerative colitis［J］.Chin J Nat Med，2023，21（4）：263-278.
113. 113.
     YANG S C，HU C，CHEN X M，et al.Crosstalk between metabolism and cell death in tumorigenesis［J］.Mol Cancer，2024，23（1）：71.
114. 114.
     GU Q，XIA H，SONG Y Q，et al.SLC6A14 promotes ulcerative colitis progression by facilitating NLRP3 inflammasome-mediated pyroptosis［J］.World J Gastroenterol，2023，30（3）：252-267.
115. 115.
     LI C X，XU Y，GAO T J，et al.Ruxolitinib alleviates inflammation，apoptosis，and intestinal barrier leakage in ulcerative colitis via STAT3［J］.Inflamm Bowel Dis，2023，29（8）：1191-1201.
116. 116.
     XU Y Y，ZHAO Z P，LI R Z，et al.Microscopic mechanism of chronic liver disease and novel thinking of medicine management based on theory of "Yang transforming Qi while Yin constituting form-sweat pore"［J］.Chin J Exp Tradit Med Form，2025，31（4）：244-255.
117. 117.
     YOU H X，YANG X Y，LUO Y Y，et al.Study on therapeutic mechanism of different ratios of Rhei Radix et Rhizoma，Aurantii Fructus immaturus and Magnoliae Officinalis Cortex from "traditional Chinese medicine-component-target" based on dose-effect relationship［J］.Chin Tradit Herbal Drugs，2024，55（20）：7021-7032.
118. 118.
     HSU K Y，HO C T，PAN M H.The therapeutic potential of curcumin and its related substances in turmeric：From raw material selection to application strategies［J］.J Food Drug Anal，2023，31（2）：194-211.
119. 119.
     HUANG M F，WU Y，LI Y T，et al.Circadian clock-related genome-wide mendelian randomization identifies putatively genes for ulcerative colitis and its comorbidity［J］.BMC Genom，2024，25（1）：130.
120. 120.
     ZENG Y，QIU H A，LIU K，et al.Exploration on taking medicine at selected time in Piwei Lun based on the time medicine［J］.China J Tradit Chin Med Pharm，2024，39（9）：5015-5017.